The Eighth Annual International Employment Survey - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Eighth Annual International Employment Survey


Pharmaceutical Technology



Figure 4: Salary according to job function.
Salary according to job function. The five highest paying jobs were in consulting, production management, computer information services and technology, drug delivery, and biopharmaceutics (see Figure 4). Most fields showed an increase in their mean base annual salaries compared with values reported in last year's survey.




Salary according to location. On average, employees in Northeastern and Western states earned the highest salaries (see Figure 5). Salaries in these regions were nearly 45% higher than those in Puerto Rico, which reported in the lowest values.

Benefits. The most common benefits include general health insurance, dental or supplemental health insurance, life insurance, and employer-provided 401k match contributions (see Table III). Other benefits that were reported but not listed in the questionnaire include flexible spending accounts, vision care, and health-club memberships.


Figure 5: Mean annual base salary
On average, employees are granted 10 paid public holidays and 18.7 paid vacation days, though most took only 15 days of vacation and admitted to doing some work (e.g., checking e-mail, returning calls) for at least 4 of these days.

Attitudes toward current employment


Table III: Percent age of respondents receiving the following employer-provided benefits.
Survey participants indicated how strongly they agreed or disagreed with the following statements:
  • I believe my work is fully valued by my employer.
  • I believe my present job is secure.
  • In my present job, I use my skills and training to the fullest extent.
  • Given the opportunity, I would leave my present job.

Most respondents continue to feel secure in their jobs, agree that their employer values their work, and believe that they use their skills to the fullest extent in their present jobs (see Table IV). US-only results show that 52% of workers either agreed or strongly agreed that they would leave their present job if given the opportunity, a 6% increase from last year.


Table IV: Opinions toward current employment.
Income, geographic location, and the opportunity for professional advancement were the three most important factors that would be taken into consideration for making this change. About 30% of respondents considered job security, intellectual challenge, and job environment to be top-level decision factors in considering a job change. The least important factors for making a job change were scientific opportunities, vacation entitlement, and health and safety.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here